The Management of Coagulopathy and Blood Loss in Liver Surgery

Seminars in Hematology

Volumn 41, Issue 1 SUPPL. 1, 2004, Pages 132-139

  Silva, Michael A ^a   Muralidharan, Vijayaragavan ^a   Mirza, Darius F ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ANESTHESIA; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDICATION; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; LIVER RESECTION; LIVER SURGERY; LIVER TRANSPLANTATION; PATIENT MONITORING; PERIOPERATIVE PERIOD; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOELASTOGRAPHY;

EID: 0842320981     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2003.11.022     Document Type: Conference Paper

References (83)

1. Amitrano L, Guardascione MA, Brancaccio V, et al: Coagulation disorders in liver disease. Semin Liver Dis 22:83-96, 2002
2. Azoulay D, Astarcioglu I, Bismuth H, et al: Split liver transplantation - The Paul Brousse policy. Ann Surg 224:737-748, 1996
3. Bayly PJ, Thick M: Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. Br J Anaesth 73:840-842, 1994
4. Ben-Ari Z, Panagou M, Patch D, et al: Hypercoagulobility in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thromboelastography. J Hepatol 26:554-559, 1997
5. Berlakovich GA: Clinical outcome of orthotopic liver transplantation. Int J Artif Organs 25:935-938, 2002
6. Bernstein D: Effectiveness of recombinant factor VIIa in patients with coagulopathy of advanced Child's B and C cirrhosis. Semin Thromb Hemost 26:437-438, 2000
7. Bernstein DE, Jeffers L, Erhardtsen E, et al: Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterology 113:1930-1937, 1997
8. Bernthal EM: Inadvertent hypothermia prevention: The anaesthetic nurses' role. Br J Nurs 8:17-25, 1999
9. Bismuth H, Houssin D: Reduced sized orthotopic liver graft in hepatic transplantation in children. Surgery 95:367-370, 1984
10. Blumgart LH: Liver resection for benign disease and for liver and biliary tumours, in Bumgart LH, Fong Y (eds): Surgery of the liver and biliary tract. London, UK, Saunders, 2000, pp 251-256
11. Bontempo FA, Lewis JH, Van Thiel DH, et al: The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 39:532-536, 1985
12. Bosch J, Abraldes JG, Groszmann R: Current management of portal hypertension. J Hepatol 38:S54-68, 2003 (suppl)
13. Boyer TD: Transjugular intrahepatic portosystemic shunt: Current status. Gastroenterology 124:1700-1710, 2003
14. Boylan JF, Klinck JR, Sandler AN, et al: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85:1043-1048, 1996
15. Brammer RD, Bramhall SR, Mirza DF, et al: A 10-year experience of complex liver trauma. Br J Surg 89:1532-1537, 2002
16. Broelsch CE, Burdelski M, Rogiers X, et al: Living donor for liver transplantation. Hepatology 20:49-55S, 1994
17. Broelsch CE, Emond JC, Whitington PF, et al: Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212:368-375 discussion 375-377, 1990
18. Cales P, Desmorat H, Vinel JP, et al: Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding. Gut 31:1298-1302, 1990
19. Cohn SM, Cross JH, Ivy ME, et al: Fibrin glue terminates massive bleeding after complex hepatic injury. J Trauma 45:666-672, 1998
20. Collins JC, Sarfeh IJ: Surgical management of portal hypertension. West J Med 162:527-535, 1995
21. Cottam S, Hunt B, Segal H, et al: Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation. Transplant Proc 23:1933, 1991
22. Cunningham JD, Fong Y, Shriver C, et al: One hundred consecutive hepatic resections: Blood loss, transfusion, and operative technique. Arch Surg 129:1050-1056, 1994
23. Deakin M, Gunson BK, Dunn JA, et al: Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Eng 75:339-344, 1993
24. Ejlersen E, Melsen T, Ingerslev J, et al: Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 36:1081-1085, 2001
25. Evans PM, Vogt DP, Mayes JT, et al: Liver resection using total vascular exclusion. Surgery 124:807-813, 1998
26. Figueras J, Llado L, Ramos E, et al: Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study. Liver Transpl 7:904-911, 2001
27. Friend PJ, Lim S, Smith M: Liver transplantation in Cambridge/Kings College Hospital series - the first 400 patients. Transplant Proc 21:2397-2398, 1989
28. Gillies BS: Thromboelastography and liver transplantation. Semin Thromb Hemost 21:45-49, 1995 (suppl)
29. Hedner U, Erhardtsen E: Potential role for rFVIIa in transfusion medicine. Transfusion 42:144-124, 2002
30. Hendriks HG, Meijer K, de Wolf JT, et al: Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study. Transplantation 71:402-405, 2001
31. Hendriks HG, Meijer K, de Wolf JT, et al: Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 13:309-13, 2002
32. Hendriks HG, Van der Meer J, Klompmaker IJ, et al: Blood loss in orthotopic liver transplantation: A retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 11:S8793, 2000 (suppl)
33. Heriot AG, Karanjia ND: A review of techniques for liver resection. Ann R Coll Surg Engl 84:371-380, 2002
34. Hoffman M, Monroe DM 3rd: The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Dis Mon 49:14-21, 2003
35. Hu RH, Lee PH, Chang YC, et al: Treatment of centrally located hepatocellular carcinoma with central hepatectomy. Surgery 133:251-256, 2003
36. Imber C, Patel N, Coldham C, et al: Hepatic steatosis/steatohepatitis (NASH) in a cohort of patients undergoing liver resection for metastatic adenocarcinoma - Does it affect outcome? Br J Surg 90:124, 2003 (suppl, abstr)
37. Jurlander B, Thim L, Klausen NK, et al: Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development. Semin Thromb Hemost 27:373-384, 2001
38. Kalicinski P, Kaminski A, Drewniak T, et al: Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 31:378-379, 1999
39. Kang YG, Martin DJ, Marqez J, et al: Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anaesth Analg 64:888-896, 1985
40. Key NS, Aledort LM, Beardsley D, et al: Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (NovoSeven®) in haemophiliacs with inhibitors. Thromb Haemost 80:912-918, 1998
41. Kimura F, Miyazaki M, Suwa T, et al: Evaluation of total hepatic vascular exclusion and Pringle maneuver in liver resection. Hepatogastroenterology 49:225-230, 2002
42. Kirby R, McMaster P, Clements D, et al: Orthotopic liver transplantation: Postoperative complications and their management. Br J Surg 74:3-11, 1987
43. Kristensen J, Killander A, Hippe E, et al: Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26:159-164, 1996 (suppl)
44. Lisman T, Leebeek FW, de Groot PG: Haemostatic abnormalities in patients with liver disease. J Hepatol 37:280-287, 2002
45. Lisman T, Mosnier LO, Lambert T, et al: Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Blood 99:175-179, 2002
46. Lodge P, Jonas S, Jaeck D, et al: Recombinant factor VIIa (NovoSeven®) in partial hepatectomy: A randomized, placebo-controlled, double-blind clinical trial. Presented at the American Association for the Study of Liver Diseases Annual Meeting, Boston, MA, Nov 2002 (abstr 177)
47. Mallett S, Rolles K, Cox D, et al: Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation. Transplant Proc 23:1931-1932, 1991
48. Mammen EF: Coagulation defects in liver disease. Med Clin North Am 78:545-554, 1994
49. Mirza DF, Achilleos O, Pirenne J, et al: Encouraging results of split-liver transplantation. Br J Surg 85:494-497, 1998
50. Molenaar IQ, Legnani C, Groenland TH, et al: Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect. Liver Transplant 7:896-903, 2001
51. Molmenti EP, Marsh JW, Fung JJ, et al: Rapid temporary portosystemic bypass. Dig Dis Sci 47:448-449, 2002
52. Monroe DM, Hoffman M, Oliver JA, et al: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-545, 1997
53. Morrissey JH, Macik BG, Neuenschwander PF, et al: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734-744, 1993
54. Moysey J, Freeman JW: Liver transplantation: Anesthesia, perioperative management and postoperative intensive care, in Blumgart LH, Fong Y (eds): Surgery of the Liver and Biliary Tract. London, UK, Saunders, 2000, pp 2035-2054
55. Murkin JM: A novel hemostatic agent: The potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. Can J Anaesth 49:S21-26, 2002
56. Neuberger J, McMaster P: Liver transplantation: Indications, in Blumgart LH, Fong Y (eds): Surgery of the Liver and Biliary Tract. London, UK, Saunders, 2000, pp 2055-2069
57. Noujaim HM, Gunson B, Mirza DF, et al: Ex-situ preparation of left split-liver grafts with left vascular pedicle only: Is it safe? A comparative single-center study. Transplantation 74:1386-1390, 2002
58. Noun R, Elias D, Balladur P, et al: Fibrin glue effectiveness and tolerance after elective liver resection: A randomized trial. Hepatogastroenterology 43:221-224, 1996
59. Oldhafer KJ, Lang H, Schlitt HJ, et al: Long-term experience after ex situ liver surgery. Surgery 127:520-527, 2000
60. Papatheodoridis GV, Burroughs AK: Hemostasis in hepatic and biliary disorders, in Blumgart LH, Fong Y (eds): Surgery of the Liver and Biliary Tract. London, UK, Saunders, 2000, pp 199-216
61. Poon MC, Demers C, Jobin F, et al: Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 94:3951-3953, 1999
62. Porte RJ: Coagulation and fibrinolysis in orthotopic liver transplantation: Current views and insights. Semin Thromb Hemost 19:191-196, 1993
63. Porte RJ, Bontempo FA, Knot EA, et al: Systemic effects of tissue plasminogen activator associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 47:978-984, 1989
64. Porte RJ, Knot EA, Bontempo FA: Hemostasis in liver transplantation. Gastroenterology 97:488-501, 1989
65. Porte RJ, Leebeek FW: Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62:2193-2211, 2002
66. Porte RJ, Molenaar IQ, Begliomini B, et al: Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study. EMSALT Study Group. Lancet 355:1303-1309, 2000
67. Postema RR, Plaisier PW, ten Kate FJ, et al: Haemostasis after partial hepatectomy using argon beam coagulation. Br J Surg 80:1563-1565, 1993
68. Rapaport SI, Rao LV: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 12:1111-1121, 1992
69. Ritter DM, Rettke SR, Lunn RJ, et al: Preoperative coagulation screen does not predict intraoperative blood product requirements in orthotopic liver transplantation. Transplant Proc 21:3533-3534, 1989
70. Rouch DA, Thistlethwaite JR, Lichtor L, et al: Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc 20:1135-1137, 1988
71. Salooja N, Perry DJ: Thrombelastography. Blood Coagul Fibrinolysis 12:327-337, 2001
72. Scholz T, Solberg R, Okkenhaug C, et al: The significance of heparin-coated veno-venous bypass circuits in liver transplantation. Perfusion 17:45-50, 2002
73. Shimada H, Endo I, Sugita M, et al: Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbecks Arch Surg 388:33-41, 2003
74. Starzl TE, Marchioro TL, Porter KA, et al: Homotransplantation of the liver. Transplantation 5:790-803, 1967 (suppl)
75. Steib A, Freys G, Lehmann C, et al: Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth 48:1075-1079, 2001
76. Sugo H, Mikami Y, Matsumoto F, et al: Hepatic resection using the harmonic scalpel. Surg Today 30:959-962, 2000
77. ten Cate H, Bauer KA, Levi M, et al: The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 92:1207-1212, 1993
78. Tokunaga Y, Tanaka K, Uemoto S, et al: Fibrin sealant of the cut surface of partial liver grafts from living donors. J Invest Surg 8:243-251, 1995
79. Torzilli G, Makuuchi M, Inoue K: The vascular control in liver resection: Revisitation of a controversial issue. Hepatogastroenterology 49:28-31, 2002
80. Tzakis A, Todo S, Starzl TE: Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 210:649-652, 1989
81. Vaezy S, Martin R, Schmiedl U, et al: Liver hemostasis using high-intensity focused ultrasound. Ultrasound Med Biol 23:1413-1420, 1997
82. Whitten CW, Greilich PE: Thromboelastography: past, present, and future. Anesthesiology 92:1223-1225, 2000
83. Wildgoose P, Nemerson Y, Hansen LL, et al: Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 80:25-28, 1992